These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33125908)

  • 1. The quest for efficient trial designs in precision oncology.
    Schuler M
    Lancet Oncol; 2020 Dec; 21(12):1539-1541. PubMed ID: 33125908
    [No Abstract]   [Full Text] [Related]  

  • 2. Precision oncology giveth and precision oncology taketh away.
    Saltz LB
    Lancet Oncol; 2019 Apr; 20(4):464-466. PubMed ID: 30857958
    [No Abstract]   [Full Text] [Related]  

  • 3. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trials.
    LoRusso PM; Freidlin B
    J Natl Cancer Inst; 2023 Feb; 115(2):122-124. PubMed ID: 36448688
    [No Abstract]   [Full Text] [Related]  

  • 5. Genomic Alteration-Driven Clinical Trial Designs in Oncology.
    Simon R
    Ann Intern Med; 2016 Aug; 165(4):270-8. PubMed ID: 27214515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
    Gupta S; Smith TR; Broekman ML
    J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Precision medicine in oncology: Challenges, stakes and new paradigms].
    Cox S; Rousseau-Tsangaris M; Abou-Zeid N; Dalle S; Leurent P; Cutivet A; Le HH; Kotb S; Bogaert B; Gardette R; Baran Y; Holder JM; Lerner L; Blay JY; Cambrosio A; Tredan O; Denèfle P
    Bull Cancer; 2019 Feb; 106(2):97-104. PubMed ID: 30713005
    [No Abstract]   [Full Text] [Related]  

  • 8. Future Approaches to Precision Oncology-Based Clinical Trials.
    Mittra A; Moscow JA
    Cancer J; 2019; 25(4):300-304. PubMed ID: 31335395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Problematic Biomarker Trial Design.
    Freidlin B; Korn EL
    J Natl Cancer Inst; 2022 Feb; 114(2):187-190. PubMed ID: 34289052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bringing Precision Medicine to Community Oncologists.
    Cancer Discov; 2017 Jan; 7(1):6-7. PubMed ID: 27864232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Oncology: 2022 in Review.
    Rosen E; Drilon A; Chakravarty D
    Cancer Discov; 2022 Dec; 12(12):2747-2753. PubMed ID: 36458431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
    Ersek JL; Black LJ; Thompson MA; Kim ES
    Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Welcome to the 16th volume of
    Jenkins R; Gautier L
    Future Oncol; 2020 Jan; 16(1):4247-4250. PubMed ID: 31797678
    [No Abstract]   [Full Text] [Related]  

  • 15. [Orientation of medical oncology treatment in precision medicine era].
    Shi Y; Sun Y
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(31):2518-21. PubMed ID: 26711383
    [No Abstract]   [Full Text] [Related]  

  • 16. Definitions and statistical properties of master protocols for personalized medicine in oncology.
    Renfro LA; Mandrekar SJ
    J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of precision oncology basket and umbrella trials for clinicians.
    Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
    CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
    Morgan G; Aftimos P; Awada A
    Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Society of Clinical Oncology Developing First Clinical Trial.
    Brower V
    J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
    [No Abstract]   [Full Text] [Related]  

  • 20. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.